Loading live market data…

Travere Therapeutics, Inc.

NASDAQ:TVTX

$56.74 USD

-$0.32 (-0.56%)

Volume
775.02K
Average Volume
2.23M
Market Capitalization
$5.28B
P/E Ratio
-115.80
Dividend Yield
0.00%
Price Target
$65.00
Year High
$60.10
Year Low
$15.03
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.13

TVTX Estimated and Actual Revenue by Quarter

TVTX Estimated and Actual EPS by Quarter

TVTX Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2027-12-31 4 -271.14M -196.27M -227.74M -279.63M -202.41M -234.87M
2027-09-30 5 -247.46M -179.12M -207.85M -255.2M -184.73M -214.35M
2027-06-30 4 -224.38M -162.42M -188.47M -231.41M -167.5M -194.36M
2027-03-31 4 -197.29M -142.81M -165.71M -203.47M -147.28M -170.9M
2026-12-31 8 -217.86M -157.7M -182.99M -224.68M -162.64M -188.72M
2026-09-30 9 -163.66M -135.11M -143.73M -168.79M -139.34M -148.23M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2027-12-31 4 83.91M 127.62M 102.28M 318.15M 439.52M 369.16M
2027-09-30 5 60.29M 91.7M 73.5M 290.36M 401.13M 336.92M
2027-06-30 4 48.74M 74.13M 59.41M 263.28M 363.72M 305.5M
2027-03-31 4 30.4M 46.23M 37.05M 231.5M 319.81M 268.62M
2026-12-31 8 38.7M 58.86M 47.17M 255.63M 353.15M 296.62M
2026-09-30 9 -25.15M 28.5M -6.71M 219.02M 265.3M 232.99M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2027-12-31 4 248.14M 342.81M 287.93M 2 0.91332 1.38916 1.11333
2027-09-30 5 226.47M 312.86M 262.78M 2 0.65628 0.9982 0.8
2027-06-30 4 205.35M 283.69M 238.28M 2 0.53049 0.80688 0.64667
2027-03-31 4 180.56M 249.44M 209.51M 2 0.33087 0.50325 0.40333
2026-12-31 8 199.38M 275.44M 231.35M 4 0.42125 0.64072 0.5135
2026-09-30 9 170.82M 206.92M 181.72M 6 -0.27372 0.31022 -0.072993